chemotherapy-induced neuropathic pain Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models.

Pain Res Manag. 2018 Jul 25;2018:5234943. doi: 10.1155/2018/5234943. eCollection 2018. Masocha W1. Author information Abstract…

Freedom WaresAugust 30, 2018

Canna~Fangled Abstracts

Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

Br J Pharmacol. 2017 May 26. doi: 10.1111/bph.13887. King KM1, Myers AM1, Soroka-Monzo AJ1, Tuma…

Freedom WaresMay 26, 2017

Canna~Fangled Abstracts

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal.

2014 Apr 25. pii: S0006-3223(14)00274-1. doi: 10.1016/j.biopsych.2014.04.009. Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance…

Freedom WaresApril 25, 2014

Canna~Fangled Abstracts

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy.

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or…

Freedom WaresOctober 17, 2013

chemotherapy-induced neuropathic pain

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models.

Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal.

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy.

Recent Posts

Archives

Categories